Objectives-(a) To assess the echocardiographic incidence of restenosis after successful balloon dilatation of the mitral valve at a mid-term follow up of one year among a population of predominantly United Kingdom patients. (b) To identify any factors, assessed before or during dilatation, which may predict the development of restenosis. Design-Successful dilatation of the mitral valve was defined as an increase in mitral valve area of >25% and a final valve area of at least 1-5 cm2. Echocardiographic restenosis was defined at follow up as a loss of 50% of initial gain and a valve area of less than 1'5 cm2.
Mitral valve area was assessed by transthoracic echocardiography before, during, 48 hours after, and one year after successful balloon dilatation of the mitral valve. Echo score before dilatation (an assessment of valvar and subvalvar calcification, thickening, and mobility), age, rhythm, echocardiographic mitral valve area before and after dilatation, left atrial pressure before and after dilatation, and end diastolic mitral valve gradient before and after dilatation were compared in those patients with and without echocardiographic restenosis at one year.
Setting-A regional cardiothoracic centre in the United Kingdom that performs 20-30 balloon dilatations of mitral valves each year. Patients-39 patients, with symptomatic dominant mitral stenosis, who had undergone successful balloon dilatation of the mitral valve, and in whom echocardiographic assessment of mitral valve area was available at one year. 92% of patients were citizens of the United Kingdom.
Interventions-Balloon dilatation of the mitral valve by the Inoue technique.
Main outcome measures-Mitral valve area and patient symptom class (New York Heart Association) one year after successful dilatation of the mitral valve. Results-The incidence of echocardiographic restenosis was eight of 39 patients (21%). Of the eight patients with restenosis four underwent mitral valve replacement, two had repeat dilatation of the mitral valve, and two remained on medical treatment. With univariant analysis, factors associated with restenosis were increased age, higher echo score before dilatation, and a lower mitral valve area immediately after the operation. The only independent risk factor for restenosis, shown by multivariant analysis, was a high echo score before dilatation. There was no significant fall in mitral valve area at one year in those patients without restenosis. Most (28/31) of these patients had echocardiographic evidence of splitting of at least one commissure after dilatation compared with only two of eight patients who developed restenosis. Of 10 patients with an echo score before dilatation > 10 only two had an initially successful operation and no restenosis at one year. Conclusions-The echocardiographic incidence of restenosis after dilatation of the mitral valve by the Inoue technique in patients of the United Kingdom is 21%. The principal factor associated with restenosis is a high echo score before dilatation. Increases in mitral valve area are maintained in those patients without restenosis and it is likely that the mechanism of initial increase in valve area is different in the two groups, being commissural splitting in those patients who do not get restenosis and valve stretching in those that do. In patients with an echo score > 10 dilatation of the mitral valve should be considered only as a palliative procedure. Assessment of mitral valve areas was predominantly by direct planimetry (35 of 39 patients), with the parasternal short axis view at the level of the leaflet tips, as it is widely recognised that this method gives the most reproducible estimate of mitral valve area immediately after dilatation of the mitral valve.8 In the four patients in whom reliable planimetry of the mitral valve could not be performed, the valve area was assessed by the Doppler pressure half time method before dilatation and at one year follow up. Immediately after dilatation in these four patients the Gorlin formula was used to calculate mitral valve area. These two methods have been shown to correlate well with planimetered valve area at these times before and after dilatation.9
Before dilatation echocardiography was used to assign each patient an echo score of suitability for dilatation of the mitral valve as first described by Wilkins et al in 1988.10 With this method a score of zero to four is given for each of valve calcification, subvalvar thickening, leaflet mobility, and valve thickening. It has previously been shown that patients with a score of eight or less have better immediate and short-term outcomes after dilatation than do those with higher scores.'0 Higher echo scores are associated with more rigid calcified valves.
STATISTICAL ANALYSIS
Results are displayed as the mean (SD). Echo results before and after dilatation were compared with a paired t test. Results within subgroups were compared with a two sample t test. In an attempt to identify factors associated with restenosis, univariant and stepwise multiple regression analysis of nine variables were performed in the 39 patients in whom echocardiographic data were available at one year. The variables analysed were age, rhythm, mitral valve area before and 48 hours after dilatation, left atrial pressure before and immediately after dilatation, end diastolic mitral valve gradient before and immediately after dilatation, and echo score before dilatation. A p value <0 05 was considered significant.
Results
MITRAL VALVE AREA Figure 1 shows changes in mitral valve area for the whole group before dilatation, 48 hours after dilatation, and at one year. Before dilatation mean mitrial valve area was 0-99 (0.21) cm2. There was a highly significant increase in valve area 48 hours after mitral dilatation (1-84 (0 33) cm2, p < 0-0001). At one year there had been a significant fall in mitral valve area for the group as a whole (1-67 (0A42) cm2, p < 0-01). The Echocardiographic restenosis occurred in eight of 39 patients (21 %) (fig 2) . Mean mitral valve area before dilatation was similar in those pat-ients who went on to develop echocardiographic restenosis and in those who did not (1.0 (0 29) cm2 v 0-99 (0-19) cm2, NS). Forty eight hours after dilatation, however, mean mitral valve area was significantly lower in the restenotic compared with the non-restenotic group (1-6 (0-18) cm2 v 1-9 (0-33) cm2, p < 0.01). In those patients without restenosis there was no significant fall in valve area at one year (1 -9 (0-33) cm2 v 1-8 (0-32) cm2, NS)-suggesting that the restenosis process may be an all or nothing phenomenon. Planimetry could not be reliably performed in two patients from the nonrestenotic group and another two patients from the restenotic group. Figure 3 shows changes in functional class for the whole group, and specifically in the restenotic subgroup.
For the whole group before dilatation most patients were in functional class 2 or 3 with six patients in class 4 (fig 3(A) (fig 4(A) ). Figure 4(B) shows results for patients with a high echo score before dilatation. We have attempted dilatation of the mitral valve in 10 patients with an echo score of > 10. Three patients had an initial suboptimal result, two failed to have a final valve area of 1 5 cm2 and one developed acute mitral regurgitation requiring urgent mitral valve replacement. Of the remaining seven patients six had an initial improvement in functional class. At one year five patients had echocardiographic restenosis resulting in only 20% (two of 10) of these patients having sustained benefit from the operation (fig 4(B) 1 (0.18)) group Our results show that dilatation of the valve should be considered as a viable option for treatment of United Kingdom patients with symptomatic dominant mitral stenosis, with a primary success rate of 94% and 95% of patients being in NYHA class 1 or 2 after the operation. The incidence of echocardiographic restenosis is however considerable, in this series being 21% (eight of 39). Univariant analysis indicated that those patients who went on to develop restenosis were older, had a higher echo score before dilatation, and had a lower mitral valve area after the operation than those patients who maintained their mitral valve area at one year. Despite this last risk factor, it cannot be recommended that increased balloon sizes should be used if, after use of the maximum recommended balloon size, a successful dilatation has been achieved but an ideal valve area (from our data about 1 Figure 4 shows the results of our experience in performing dilatation of the mitral valve in the elderly and in those with a high echo score before dilatation.
Our results shows that dilatation is a valuable interventional option in elderly patients in the United Kingdom with mitral stenosis. Ten out of 13 patients had an initial improvement of at least one NYHA functional class after the operation and 54% (seven of 13) of this elderly group were in class 1 or 2 at one year. The results for patients with a high echo score before dilatation are less encouraging. Six of our 10 patients in this subgroup did have an initial improvement in functional class. At one year, however, only 20% (two of 10) of these patients had a sustained benefit from the operation (fig 4(B) ).
The mechanism for the increase in valve area after dilatation of the mitral valve is generally thought to be commissural splitting.45
Some authors have described valve stretching as contributing to the increase in valve area.21
There was echocardiographic evidence of splitting of at least one commissure in 28 of 31 patients who did not develop restenosis whereas commissural splitting was only convincingly found in two of eight patients who went on to develop echocardiographic restenosis. These data suggest that the mechanism for the increase in valve area may have been different in the two groups, in one being due to commissural splitting and in the other due to valve stretching. Restenosis Of the factors associated with echocardiographic restenosis the most important seems to be a high echo score before operation: patients with an echo score of > 10 have particularly disappointing results with an increased incidence of initial suboptimal results and often only short-term increases in mitral valve area. Balloon dilatation of the mitral valve should, therefore, only be considered as a palliative procedure in this subgroup of patients.
